A review of prognostic and predictive biomarkers in breast cancer

E Tarighati, H Keivan, H Mahani - Clinical and experimental medicine, 2023 - Springer
Breast cancer (BC) is a common cancer all over the world that affects women. BC is one of
the leading causes of cancer mortality in women, which today has decreased with the …

[HTML][HTML] Non-invasive biomarkers for early detection of breast cancer

J Li, X Guan, Z Fan, LM Ching, Y Li, X Wang, WM Cao… - Cancers, 2020 - mdpi.com
Simple Summary Early diagnosis of breast cancer greatly increases the chance of cure and
survival from the disease. The mammogram is widely used for early detection of breast …

On the (statistical) detection of adversarial examples

K Grosse, P Manoharan, N Papernot, M Backes… - arXiv preprint arXiv …, 2017 - arxiv.org
Machine Learning (ML) models are applied in a variety of tasks such as network intrusion
detection or Malware classification. Yet, these models are vulnerable to a class of malicious …

[HTML][HTML] Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246

T Cooks, IS Pateras, LM Jenkins, KM Patel… - Nature …, 2018 - nature.com
Abstract TP53 mutants (mutp53) are involved in the pathogenesis of most human cancers.
Specific mutp53 proteins gain oncogenic functions (GOFs) distinct from the tumor …

[HTML][HTML] Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers

R Hamam, D Hamam, KA Alsaleh, M Kassem… - Cell death & …, 2017 - nature.com
Effective management of breast cancer depends on early diagnosis and proper monitoring
of patients' response to therapy. However, these goals are difficult to achieve because of the …

[HTML][HTML] Plasma exosome microRNAs are indicative of breast cancer

BN Hannafon, YD Trigoso, CL Calloway, YD Zhao… - Breast cancer …, 2016 - Springer
Background microRNAs are promising candidate breast cancer biomarkers due to their
cancer-specific expression profiles. However, efforts to develop circulating breast cancer …

[HTML][HTML] Integrated extracellular microRNA profiling for ovarian cancer screening

A Yokoi, J Matsuzaki, Y Yamamoto, Y Yoneoka… - Nature …, 2018 - nature.com
A major obstacle to improving prognoses in ovarian cancer is the lack of effective screening
methods for early detection. Circulating microRNAs (miRNAs) have been recognized as …

Circulating miRNA panels for specific and early detection in bladder cancer

W Usuba, F Urabe, Y Yamamoto, J Matsuzaki… - Cancer …, 2019 - Wiley Online Library
Bladder cancer is the 9th leading cause of cancer death worldwide. The major problem in
bladder cancer is primarily the high recurrence rate after drug treatment and resection …

[HTML][HTML] Liquid biopsy as a tool for the diagnosis, treatment, and monitoring of breast cancer

AJA Freitas, RL Causin, MB Varuzza, S Calfa… - International journal of …, 2022 - mdpi.com
Breast cancer (BC) is a highly heterogeneous disease. The treatment of BC is complicated
owing to intratumoral complexity. Tissue biopsy and immunohistochemistry are the current …

Circulating microRNAs: Biomarkers of disease

Y Wu, Q Li, R Zhang, X Dai, W Chen, D Xing - Clinica Chimica Acta, 2021 - Elsevier
MicroRNAs are a class of endogenous noncoding single-stranded RNA molecules with
approximately 20–24 nucleotides and are associated with a broad range of biological …